A pharmaceutical company in Northern Ireland has announced plans to double capacity over the next three years - a move that could create up to 60 jobs.
The expansion at Almac in Craigavon, Co Armagh, is expected to create between 50 and 60 new jobs as the facility develops.
The posts will be in analytical and development roles as well as indirect support roles.
Two new laboratories are to be built along with a new 13,400ft facility, following the completion of the first stage of a £6.5 million project.
The new facility will focus on developing tablets for new drugs that have not yet reached the market.
As the drugs are intended for use in manufacturing rather than human use, it is hoped that work will be able to progress more quickly due to fewer of the constraints usually associated with drug manufacturing.
John McQuaid, of Almac, said the expansion was a welcome addition to its existing facilities.
"We can now offer a very attractive package to our clients, with a larger and more competitive service offering within the international drug development arena," he said.
Mr McQuaid added: "As the new facility effectively doubles our current pharmaceutical development capacity, recruitment of experienced, skilled staff has already started. As 2013 and the facility's capacity progress, further jobs will be advertised."
Almac provides services to more than 600 companies, including world leaders in the pharmaceutical and biotech sectors.